AMD Drug Can Prevent Vision Loss in Diabetics With Diabetic Macular Edema
RPB-supported researchers at the University of Southern California (USC) report that ranibizumab (sold as Lucentis) can help Hispanic and non-Hispanic whites with diabetic macular edema (DME) in the United States avoid visual impairment and blindness. Diabetic retinopathy and DME are the leading causes of vision loss in working-age adults in the United States.
February 20, 2015
Related News: Top Story
Research to Prevent Blindness Celebrates 65 Years of Success
Since 1960, RPB has been transforming vision research and eyecare for the benefit of all people
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2025 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Maria Bartolomeo Grant, MD, is recognized for ground-breaking contributions to the field of vision research.
The Time is Now to Protect the National Eye Institute
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
RPB Grantees Contribute to Eye Transplantation Effort
The ARPA-H THEA project takes on an exciting challenge.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2025 Research to Prevent Blindness. All Rights Reserved.
